[{"orgOrder":0,"company":"THERAPIM PTY LTD","sponsor":"Novotech","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"","productType":"Other Small Molecule","year":"2021","type":"Inapplicable","leadProduct":"Sodium Deoxycholate","moa":"Cell membrane","graph1":"Oncology","graph2":"Phase I\/ Phase II","graph3":"THERAPIM PTY LTD","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Intravenous","sponsorNew":"THERAPIM PTY LTD \/ Novotech","highestDevelopmentStatusID":"7","companyTruncated":"THERAPIM PTY LTD \/ Novotech"}]

Find Clinical Drug Pipeline Developments & Deals for Sodium Deoxycholate

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          October 15, 2012

                          Lead Product(s) : Sodium Deoxycholate

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase I

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Abbvie CB

                          02

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          March 22, 2011

                          Lead Product(s) : Sodium Deoxycholate

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase I

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Abbvie CB

                          03

                          THERAPIM PTY LTD

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          THERAPIM PTY LTD

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          March 24, 2021

                          Lead Product(s) : Sodium Deoxycholate

                          Therapeutic Area : Oncology

                          Highest Development Status : Phase I/ Phase II

                          Sponsor : Novotech

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          Goldman, Butterwick, Fitzpatrick and Groff

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Goldman, Butterwick, Fitzpatrick and Groff

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          December 04, 2017

                          Lead Product(s) : Sodium Deoxycholate

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase IV

                          Sponsor : Allergan | Maryland Laser Skin & Vein Institute

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          Goldman, Butterwick, Fitzpatrick and Groff

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Goldman, Butterwick, Fitzpatrick and Groff

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          August 07, 2017

                          Lead Product(s) : Sodium Deoxycholate

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Phase IV

                          Sponsor : Allergan

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank